Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...

and packaging of Sanofi’s SoloStar insulin pens and advanced insulin products. This strategic partnership reinforces our commitment to reduce the burden of importing medicines, increase access to high ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of some insulin products, in partnership with National Unified Procurement Co.

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

As usual, you can find the slides on sanofi.com. Please turn to Slide number ... to grow by a high-single-digit percentage.

A Sanofi official told lawmakers the company ... patients and have proven more lucrative for manufacturers than insulin products. Over the past five years, GLP-1s have surpassed insulin as the ...

The Act pressured pharmaceutical companies to lower drug prices: this year, Novo Nordisk and Sanofi lowered the cost of their ...